EPHB4 and ovarian carcinoma: To discover additional molecular therapeutic targets that may be incorporated into a multimodality regimen for the treatment of ovarian cancer, we studied the expression and localisation of the EphB4 receptor and the corresponding ephrinB2 ligand in ovarian cancers to analyse EphB4/ephrinB2 functions against clinical backgrounds.